HCPCS drug code for abatacept given by injection or infusion in a clinic, billed in 10 mg units, used mostly for rheumatoid arthritis.
- Medicare
- $0.00
- Work RVU
- 0
- Global, days
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 3 cited references ↓
- Diagnosis supporting use, usually moderate to severe rheumatoid arthritis
- Dose in mg, weight used for dosing, and units billed
- Infusion start and stop times for the administration code
- Lot number, NDC, and any amount discarded
- Prior therapy history if the payer requires step therapy
- Date of last dose in pre-op notes for surgical patients
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 3 cited references ↓
J0129 reports abatacept (Orencia) per 10 mg when it is given in the office or infusion center. The IV form is the one billed here. The subcutaneous pens patients use at home go through pharmacy benefits and are generally not billable on J0129.
Orthopedic practices rarely buy and bill abatacept, but you see it constantly in rheumatoid patients coming in for joint replacement, hand reconstruction, or foot surgery. Perioperative guidance from rheumatology and arthroplasty societies has surgery timed near the end of a dosing interval, so the date of the last infusion belongs in the pre-op note.
If an ortho group with an infusion suite does bill it, the drug line pays from the ASP file, not the physician fee schedule, which is why the fee schedule shows no rate. Units are total mg divided by 10, rounded up. Report the infusion administration separately, and add JW for discarded drug from a single-dose vial or JZ when nothing was wasted.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 0 |
| Practice expense RVU | 0 |
| Malpractice RVU | 0 |
| Total RVU | 0 |
| Medicare national rate | $0.00 |
| Global period | days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $0.00 |
HOPD (APC 9230) Hospital outpatient department | $44.77 |
Common denial reasons
The recurring reasons claims for CPT J0129 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- No prior authorization on file
- Units do not match the dose documented
- Missing JW or JZ modifier on a single-dose vial
- Step therapy not met for the payer's preferred biologic
- Self-administered subcutaneous form billed under J0129
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 3 cited references ↓
01How many units of J0129 for 750 mg of abatacept?
02Can J0129 be billed for Orencia ClickJect?
03Should abatacept be stopped before joint replacement?
04Does J0129 need the JZ modifier?
Sources & references
Editorial content was developed using the following public sources.
- 01CMS Physician Fee Schedule 2026
- 02CMS Medicare Part B Drug Average Sales Price files
- 03cms.govhttps://www.cms.gov/medicare/payment/fee-schedules/physician
Mira Scribe
Mira Scribe notes record the patient's biologic and the date of the last dose during the pre-op visit, which gives the surgeon and anesthesia team what they need for timing.
See how Mira captures CPT J0129 documentation